Reduced Perfusion Index as an Independent Predictor of Scleroderma Pattern on Nailfold Capillaroscopy in Patients with Systemic Sclerosis: A Cross-Sectional Study

Systemic sclerosis, often called scleroderma, is a complex autoimmune disease where the body's immune system mistakenly attacks its own tissues, leading to hardening of the skin and damage to internal organs. A central feature of this condition is the breakdown of the body's smallest blood vessels. Long before the skin hardens or organs fail, these tiny vessels begin to malfunction, narrowing or disappearing entirely. This microscopic damage restricts blood flow to the fingers and toes, causing pain, color changes, and sometimes tissue loss. To understand how severe this damage is, doctors currently rely on a technique called nailfold capillaroscopy. This involves placing a special microscope over the skin at the base of the fingernail to count and examine the tiny loops of blood vessels. While this method is considered the gold standard for diagnosis, it requires expensive equipment and a highly trained specialist, making it difficult to use in many clinics around the world.

Researchers have long sought a simpler way to gauge how well blood is flowing to the extremities. A promising candidate has emerged from a device found in nearly every hospital and clinic: the pulse oximeter. This is the small clip placed on a finger to measure oxygen levels. Hidden within its reading is a number called the perfusion index, which measures the strength of the pulse signal in the finger. A strong signal suggests good blood flow, while a weak or absent signal suggests the blood is struggling to reach the tip of the finger. The question remained whether this simple, functional number could tell doctors something meaningful about the specific, structural damage seen under the microscope in scleroderma patients.

A team of researchers at the Federal University of Paraná in Brazil set out to answer this question by studying 84 patients with systemic sclerosis. They wanted to see if the perfusion index could independently predict whether a patient showed the specific pattern of blood vessel damage known as the "scleroderma pattern." This pattern is characterized by enlarged, distorted blood vessels and a loss of capillaries, which are hallmarks of the disease. The researchers measured the perfusion index for each patient using a standard portable pulse oximeter while they sat comfortably in a clinic chair. They then compared these numbers against the results of the patients' nailfold capillaroscopy exams, which had been performed as part of their routine care.

The results revealed a clear connection between the two measurements. Patients who had the scleroderma pattern of blood vessel damage showed significantly lower perfusion index values than those who did not. Specifically, the median value for those with the damaging pattern was 0.4, compared to 1.4 for those without it. This difference was statistically significant, meaning it was unlikely to have occurred by chance. The study found that a lower perfusion index was strongly associated with the presence of the scleroderma pattern, even after the researchers accounted for other factors that could influence blood flow, such as age, sex, ethnicity, smoking history, and conditions like high blood pressure or diabetes.

To determine how well the perfusion index could distinguish between patients with and without the damaging pattern, the researchers analyzed the data using statistical tools designed to measure diagnostic accuracy. They found that the perfusion index had a moderate ability to identify the scleroderma pattern. When they set a specific threshold to prioritize accuracy, they found that patients with a perfusion index of 0.45 or lower were much more likely to have the scleroderma pattern than those with higher values. The study suggests that a very low perfusion index acts as a functional warning sign, reflecting the same underlying microvascular impairment that the microscope sees structurally.

The researchers emphasized that while the perfusion index is not a replacement for the detailed view provided by capillaroscopy, it serves as a valuable complementary tool. The two methods look at different aspects of the same problem: one examines the physical shape and number of the vessels, while the other measures how well blood is actually moving through them. Because the pulse oximeter is inexpensive, portable, and easy to use, the perfusion index could offer a practical way to screen for microvascular damage in settings where specialized microscopes are unavailable. This could be particularly helpful in resource-limited environments, allowing doctors to identify patients who need closer monitoring or further testing.

The study also addressed potential confounding factors to ensure the results were reliable. The researchers noted that conditions like diabetes can affect blood flow, and they found that patients with diabetes were actually less likely to show the scleroderma pattern in this specific group. However, this did not change the main finding: the perfusion index remained a strong, independent predictor of the scleroderma pattern regardless of other health conditions. The authors concluded that the perfusion index captures the functional reality of the disease's impact on circulation. While the study was cross-sectional, meaning it looked at a single point in time and could not prove that low perfusion causes the damage, the strong association suggests that this simple measurement reflects the true state of the microcirculation in systemic sclerosis. Future research will need to follow patients over time to see if changes in the perfusion index can predict disease progression or complications, but for now, it stands as a simple, accessible window into the hidden vascular struggles of this complex disease.